A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel.

Powell MA, Bjørge L, Willmott L, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Gropp-Meier M, Stuckey A, Boere I, Gold MA, Segev Y, Gill SE, Gennigens C, Sebastianelli A, Shahin MS, Pothuri B, Monk BJ, Buscema J, Coleman RL, Slomovitz BM, Ring KL, Herzog TJ, Balas MM, Grimshaw M, Stevens S, Lai DW, McCourt C, Mirza MR

Open source

DOI: 10.1177/17588359251342241
Published: 2025
Container: Therapeutic advances in medical oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/17588359251342241,
  title = {A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel.},
  author = {Powell MA and Bjørge L and Willmott L and Novák Z and Black D and Gilbert L and Sharma S and Valabrega G and Landrum LM and Gropp-Meier M and Stuckey A and Boere I and Gold MA and Segev Y and Gill SE and Gennigens C and Sebastianelli A and Shahin MS and Pothuri B and Monk BJ and Buscema J and Coleman RL and Slomovitz BM and Ring KL and Herzog TJ and Balas MM and Grimshaw M and Stevens S and Lai DW and McCourt C and Mirza MR},
  year = {2025},
  journal = {Therapeutic advances in medical oncology},
  doi = {10.1177/17588359251342241},
  url = {https://doi.org/10.1177/17588359251342241}
}

RIS

TY  - JOUR
TI  - A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel.
AU  - Powell MA
AU  - Bjørge L
AU  - Willmott L
AU  - Novák Z
AU  - Black D
AU  - Gilbert L
AU  - Sharma S
AU  - Valabrega G
AU  - Landrum LM
AU  - Gropp-Meier M
AU  - Stuckey A
AU  - Boere I
AU  - Gold MA
AU  - Segev Y
AU  - Gill SE
AU  - Gennigens C
AU  - Sebastianelli A
AU  - Shahin MS
AU  - Pothuri B
AU  - Monk BJ
AU  - Buscema J
AU  - Coleman RL
AU  - Slomovitz BM
AU  - Ring KL
AU  - Herzog TJ
AU  - Balas MM
AU  - Grimshaw M
AU  - Stevens S
AU  - Lai DW
AU  - McCourt C
AU  - Mirza MR
PY  - 2025
JO  - Therapeutic advances in medical oncology
DO  - 10.1177/17588359251342241
UR  - https://doi.org/10.1177/17588359251342241
ER  -

APA

MA, P., L, B., L, W., Z, N., D, B., L, G., S, S., G, V., LM, L., M, G., A, S., I, B., MA, G., Y, S., SE, G., C, G., A, S., MS, S., B, P., BJ, M., J, B., RL, C., BM, S., KL, R., TJ, H., MM, B., M, G., S, S., DW, L., C, M., & MR, M. (2025). A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel.. Therapeutic advances in medical oncology. https://doi.org/10.1177/17588359251342241

Source records

pubmed · retrieved 2026-09-26T11:33:38.982Z